Under the inherited metabolics disease program Olivia's Cystagon is covered. With the new approval, Procysbi is as well. Our access to Cystagon is through SAP right now. Currently, we have to apply every three months for Olivia to stay on this treatment as it's flawless for her. That is covered under that program.
If our family were to switch to the new drug, in Ontario specifically, or if any other families switch to the new drug, it would also be covered under the same program—the new drug, as well.